<VariationArchive VariationID="2631388" VariationName="NM_001374353.1(GLI2):c.798_804del (p.Ser266fs)" VariationType="Deletion" Accession="VCV002631388" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-19" DateCreated="2023-11-20" MostRecentSubmission="2023-11-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2803538" VariationID="2631388">
      <GeneList>
        <Gene Symbol="GLI2" FullName="GLI family zinc finger 2" GeneID="2736" HGNC_ID="HGNC:4318" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q14.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="120735868" stop="120992653" display_start="120735868" display_stop="120992653" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="121554866" stop="121750228" display_start="121554866" display_stop="121750228" Strand="+" />
          </Location>
          <OMIM>165230</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLI2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLI2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001374353.1(GLI2):c.798_804del (p.Ser266fs)</Name>
      <CanonicalSPDI>NC_000002.12:120968866:GCTCGGCG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q14.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="120968867" stop="120968873" display_start="120968867" display_stop="120968873" variantLength="7" positionVCF="120968866" referenceAlleleVCF="AGCTCGGC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="121726443" stop="121726449" display_start="121726443" display_stop="121726449" variantLength="7" positionVCF="121726442" referenceAlleleVCF="AGCTCGGC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>S141fs</ProteinChange>
      <ProteinChange>S266fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.121726444_121726450del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.121726444_121726450del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.120968868_120968874del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.120968868_120968874del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009030.1" sequenceAccession="NG_009030" sequenceVersion="1" change="g.176578_176584del">
            <Expression>NG_009030.1:g.176578_176584del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009030.2" sequenceAccession="NG_009030" sequenceVersion="2" change="g.238002_238008del">
            <Expression>NG_009030.2:g.238002_238008del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001371271.1" sequenceAccession="NM_001371271" sequenceVersion="1" change="c.798_804del">
            <Expression>NM_001371271.1:c.798_804del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001358200.1" sequenceAccession="NP_001358200" sequenceVersion="1" change="p.Ser266fs">
            <Expression>NP_001358200.1:p.Ser266fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374353.1" sequenceAccession="NM_001374353" sequenceVersion="1" change="c.798_804del" MANESelect="true">
            <Expression>NM_001374353.1:c.798_804del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361282.1" sequenceAccession="NP_001361282" sequenceVersion="1" change="p.Ser266fs">
            <Expression>NP_001361282.1:p.Ser266fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374354.1" sequenceAccession="NM_001374354" sequenceVersion="1" change="c.423_429del">
            <Expression>NM_001374354.1:c.423_429del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361283.1" sequenceAccession="NP_001361283" sequenceVersion="1" change="p.Ser141fs">
            <Expression>NP_001361283.1:p.Ser141fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005270.5" sequenceAccession="NM_005270" sequenceVersion="5" change="c.798_804del">
            <Expression>NM_005270.5:c.798_804del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005261.2" sequenceAccession="NP_005261" sequenceVersion="2" change="p.Ser266fs">
            <Expression>NP_005261.2:p.Ser266fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001374353.1(GLI2):c.798_804del (p.Ser266fs) AND GLI2-related disorder" Accession="RCV003414463" Version="4">
        <ClassifiedConditionList TraitSetID="89017">
          <ClassifiedCondition>GLI2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-11-20" MostRecentSubmission="2023-11-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="89017" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70223" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">GLI2-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLI2-related disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLI2-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7688770" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="36563387|GLI2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004106999" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The GLI2 c.798_804del7 variant is predicted to result in a frameshift and premature protein termination (p.Ser266Argfs*33). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in GLI2 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GLI2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005270.4:c.798_804del7</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLI2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7688770" TraitType="Disease" MappingType="Name" MappingValue="GLI2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="GLI2-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

